미주신경 자극기 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global vagus nerve stimulator market size is expected to reach USD 1.65 Billion in 2034 from USD 0.67 Billion in 2025, growing at a CAGR of 10.56 during 2026-2034.This market is gaining momentum due to the increasing prevalence of neurological and psychiatric disorders such as epilepsy, depression, and anxiety. Vagus nerve stimulators are advanced medical devices that deliver electrical impulses to the vagus nerve, helping regulate brain activity and manage symptoms. The growing acceptance of neurostimulation therapies as effective treatment options is significantly contributing to market growth.

The market is driven by factors such as rising healthcare expenditure, increasing awareness about neurological disorders, and advancements in medical technology. The aging population, which is more susceptible to such conditions, is also a major contributor to market expansion. Furthermore, ongoing research and clinical studies are exploring new therapeutic applications of vagus nerve stimulation, expanding its potential use cases.

Looking ahead, the market is expected to witness continuous innovation in device design and functionality, improving patient outcomes and comfort. Integration with digital health platforms will enable better monitoring and personalized treatment approaches. Increasing adoption in emerging markets and growing support from healthcare providers will further drive growth. The vagus nerve stimulator market is poised for significant development in the coming years.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product Type

• Implantable
• Non-invasive (tVNS)

By Application

• Pain Management
• Epileptic Seizures
• Obesity Management
• Depression and Anxiety
• Others

By Biomaterial

• Ceramics
• Metallic
• Polymeric

By End User

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Others

COMPANIES PROFILED

• ReShape Lifesciences Inc., LivaNova LLC, electroCore Inc., MicroTransponder Inc., Parasym Ltd., Cerebral Inc., Cerbomed GmbH, Neuvana LLC, Nevro Corp., NeuroPace Inc

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL VAGUS NERVE STIMULATOR MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Implantable Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Non-invasive (tVNS) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL VAGUS NERVE STIMULATOR MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Pain Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Epileptic Seizures Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Obesity Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Depression and Anxiety Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL VAGUS NERVE STIMULATOR MARKET: BY BIOMATERIAL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Biomaterial
• 6.2. Ceramics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Metallic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Polymeric Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL VAGUS NERVE STIMULATOR MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centers (ASCs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL VAGUS NERVE STIMULATOR MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product Type
  • 8.2.2 By Application
  • 8.2.3 By Biomaterial
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product Type
  • 8.3.2 By Application
  • 8.3.3 By Biomaterial
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product Type
  • 8.4.2 By Application
  • 8.4.3 By Biomaterial
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product Type
  • 8.5.2 By Application
  • 8.5.3 By Biomaterial
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product Type
  • 8.6.2 By Application
  • 8.6.3 By Biomaterial
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL VAGUS NERVE STIMULATOR INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 ReShape Lifesciences Inc
  • 10.2.2 LivaNova LLC
  • 10.2.3 ElectroCore Inc
  • 10.2.4 MicroTransponder Inc
  • 10.2.5 Parasym Ltd
  • 10.2.6 Cerebral Inc
  • 10.2.7 Cerbomed GmbH
  • 10.2.8 Neuvana LLC
  • 10.2.9 Nevro Corp
  • 10.2.10 NeuroPace Inc